Price, David; Asukai, Yumi; Ananthapavan, Jaithri; … - In: Applied Health Economics and Health Policy 11 (2013) 3, pp. 259-274
The analyses demonstrate that indacaterol dominates both tiotropium and salmeterol in the base case and is likely to remain cost-effective under a range of assumptions. </AbstractSection> Copyright The Author(s) 2013
